Nyxoah Sa (NYXH)

概要ニュース株価時系列ディスカッション予測

Relative Volume:

ネットキャッシュフロー:

Nyxoah Sa Stock (NYXH) Company Profile

Healthcare (1118)

NYXH's Discussions on Twitter

Compare NYXH vs ISRG, BDX, ALC, MDLN, RMD

株式	価格	時価総額	収益	当期純利益	現金流量	EPS
NYXH Nyxoah Sa	4.40	200.93M	4.71M	-46.77M	-60.34M	-1.6792
ISRG Intuitive Surgical Inc	479.59	176.19B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	178.76	51.41B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	78.54	39.00B	10.19B	1.05B	1.38B	2.1044
MDLN Medline Inc	44.18	37.48B	27.43B	1.27B	1.01B	1.5829
RMD Resmed Inc	246.96	37.82B	5.40B	1.49B	1.78B	10.12

Nyxoah Sa Stock (NYXH) Upgrades & Downgrades

日付	アクション	アナリスト	評価の変更
2023-07-31	開始されました	H.C. Wainwright	Buy
2023-07-19	開始されました	Robert W. Baird	Neutral
2022-04-21	開始されました	Oppenheimer	Outperform
2022-04-06	開始されました	Wolfe Research	Peer Perform
2021-12-21	再開されました	Cantor Fitzgerald	Overweight
2021-07-28	開始されました	Cantor Fitzgerald	Overweight

Nyxoah Sa (NYXH) 最新ニュース

Nyxoah Sa (NYXH) 財務データ

Nyxoah Sa (NYXH)

Nyxoah Sa Stock (NYXH) Company Profile

Compare NYXH vs ISRG, BDX, ALC, MDLN, RMD

Nyxoah Sa Stock (NYXH) Upgrades & Downgrades

Nyxoah Sa (NYXH) 最新ニュース

Nyxoah's Revenue On The Rise- Will The Stock Wake From Its Slumber? - RTTNews

Guidance Update: Is now the right time to enter Nyxoah SABond Market & Daily Stock Trend Watchlist - baoquankhu1.vn

Price-Driven Insight from (NYXH) for Rule-Based Strategy - Stock Traders Daily

Trading Recap: Will Nyxoah SA benefit from AI trendsQuarterly Trade Report & Low Risk Investment Opportunities - baoquankhu1.vn

Aug PreEarnings: Can Nyxoah SA sustain its profitabilityBear Alert & Expert Approved Trade Ideas - baoquankhu1.vn

Price Action: Should I hold or sell Nyxoah SA now2025 Institutional Moves & AI Driven Stock Movement Reports - baoquankhu1.vn

Ideas Watch: Is now the right time to enter Nyxoah SAQuarterly Trade Summary & High Accuracy Investment Entry Signals - baoquankhu1.vn

Will Nyxoah SA benefit from rising consumer demandWeekly Stock Report & Smart Money Movement Tracker - baoquankhu1.vn

Nyxoah (NASDAQ:NYXH) Shares Down 0.4%Time to Sell? - MarketBeat

Nyxoah (NASDAQ:NYXH) Shares Down 0.4% – Time to Sell? - Defense World

Nyxoah Expands Belgian Manufacturing Hub to Support Global Growth in OSA Therapy - TipRanks

Risk Hedge: Is Nyxoah SA stock a good dividend stockTrade Ideas & Long-Term Growth Plans - mfd.ru

Can Nyxoah SA sustain its profitabilityJuly 2025 Big Picture & AI Powered Buy and Sell Recommendations - mfd.ru

Volume Report: Can Nyxoah SA ride the EV waveQuarterly Portfolio Review & Weekly High Return Forecasts - baoquankhu1.vn

Nyxoah Expands Belgian Manufacturing Capacity to Support Global Growth - Sleep Review

Nyxoah SA (NYXH) Investor Outlook: Exploring a 137.85% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews

Nyxoah invests in further expanding its Belgian manufacturing capacity to support its worldwide growth - marketscreener.com

Nyxoah says co invests expanding its Belgian manufacturing capacity - marketscreener.com

Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth - GlobeNewswire

Does Nyxoah SA have pricing power2025 Risk Factors & Growth Focused Stock Reports - bollywoodhelpline.com

Aug Sectors: Is Flanigans Enterprises Inc stock a falling knife or bargain buy2025 Fundamental Recap & Intraday High Probability Alerts - baoquankhu1.vn

(NYXH) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

NYXH: Rapid U.S. launch and strong clinical results position Genio for significant market growth - TradingView

NYXH: Genio's innovative sleep apnea device drives rapid U.S. adoption and strong early sales - TradingView — Track All Markets

Oppenheimer Maintains Nyxoah SA(NYXH.US) With Buy Rating, Maintains Target Price $13 - 富途牛牛

Nyxoah’s First Full U.S. Sales Quarter Fuels Triple-Digit Revenue Growth in 2025 - TipRanks

Nyxoah (NASDAQ: NYXH) reports preliminary 2025 results and Q1 2026 view - Stock Titan

Stifel reiterates Buy rating on Nyxoah stock, maintains $12 price target By Investing.com - Investing.com South Africa

Stifel Maintains Nyxoah SA(NYXH.US) With Buy Rating, Maintains Target Price $12 - 富途资讯

Stifel reiterates Buy rating on Nyxoah stock, maintains $12 price target - Investing.com Australia

Is Nyxoah SA stock a safe investment in uncertain markets2025 Growth vs Value & Verified Swing Trading Watchlist - Bộ Nội Vụ

Belgium-based Nyxoah’s net revenue expected to increase 348% in Q4 2025 - Medical Buyer

Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2025 and Provides Revenue Guidance for the First Quarter of 2026 - The Manila Times

Nyxoah Shares Surge On Strong Q4 Preliminary Revenue - Nasdaq

News - FinancialContent

Publication relating to transparency notification - GlobeNewswire

Nyxoah SA's (EBR:NYXH) market cap rose €19m last week; retail investors who hold 44% profited and so did insiders - simplywall.st

Aug Opening: Is Nyxoah SA stock a contrarian buyJuly 2025 Price Swings & AI Forecasted Entry/Exit Points - Bộ Nội Vụ

Is Nyxoah SA stock a good choice for value investorsSeasonal Picks & what to check before ordering - Улправда

Is Nyxoah SA stock a contrarian buyMarket Risk Summary & Free Fast Gain Swing Trade Alerts - Улправда

How Nyxoah SA (5YI) stock benefits from digital adoptionPortfolio Growth Summary & Free Safe Entry Trade Signal Reports - ulpravda.ru

Aug Intraday: Is Nyxoah SA stock a good choice for value investors2025 Technical Overview & Community Consensus Trade Alerts - Улправда

Why Nyxoah SA stock is recommended by analysts2025 Pullback Review & Safe Entry Momentum Stock Tips - ulpravda.ru

Nyxoah SA (NYXH) Stock Analysis: Exploring a Potential 125.84% Upside in the Healthcare Sector - DirectorsTalk Interviews

Nyxoah receives Medicare reimbursement increases for Genio - MSN

Nyxoah to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times

PRN_FinancialWrapper | PR NewswireNyxoah to Present at the 44th Annual J.P. Morgan Healthcare Conference - FinancialContent

Contrasting Azenta (NASDAQ:AZTA) and Nyxoah (NASDAQ:NYXH) - Defense World

Baird Maintains Nyxoah SA(NYXH.US) With Hold Rating, Cuts Target Price to $5.87 - 富途牛牛

Nyxoah to Participate in Upcoming Investor Conferences - Macau Business

Nyxoah SA (NYXH) Stock Analysis: Exploring a 145.53% Potential Upside in the Medical Tech Sector - DirectorsTalk Interviews

Nyxoah Sa (NYXH) 財務データ

収益

当期純利益

現金流量

EPS

NYXHに似た銘柄